Wednesday, July 8, 2026
🇺🇸 FDA

Drug profile · INN

sodium chloride

BAXTER HEALTHCARE PTY LTD

sodium chloride (BAXTER HEALTHCARE PTY LTD) is an FDA-listed pharmaceutical active ingredient. Associated with BAXTER HEALTHCARE PTY LTD. Route of administration: irrigation. Current US regulatory status: approved.

FDA: approved TGA: approved
US status approved
Patents linked 20
Pipeline programs 172
News articles 1
Drug details — sodium chloride
US status
approved
Class
—
Route
IRRIGATION
Patents
20
Programs
172
Data quality
0.89
← All drugs Manufacturer profile Related patents Pipeline programs Drug news hub Event calendar

Quick answer

sodium chloride (BAXTER HEALTHCARE PTY LTD) is an FDA-listed pharmaceutical active ingredient. Associated with BAXTER HEALTHCARE PTY LTD. Route of administration: irrigation. Current US regulatory status: approved.

Key facts

INN sodium chloride
Brand BAXTER HEALTHCARE PTY LTD
Route IRRIGATION
Formulation SOLUTION FOR SLUSH
Originator BAXTER HEALTHCARE PTY LTD

Approval history

Authority Status Date
FDA approved —
TGA approved —

Recent coverage

View all news
Axsome FDA Approval for Alzheimer's Agitation Drug
Critical impact Newsagitation associated with Alzheimer's diseaseMay 3, 2026

Axsome FDA Approval for Alzheimer's Agitation Drug

FDA · agitation associated with Alzheimer's disease · 6 min

Axsome Therapeutics has received FDA approval for a new treatment for agitation associated with Alzheimer's disease. This landmark decision addresses a critical unmet need and marks a significant step forward for the company and Alzheimer's patient care.

Dr. Priya Nandakumar

Pipeline programs

Search pipeline Sponsor programs
  1. 0.9% Sodium Chloride Solution, Glenzocimab Phase 3 · PARItec · Acute ischemic stroke
  2. 0.9% Sodium Chloride, JNJ-78901563 Phase 3 · Zhejiang Xianju Pharmaceutical · Invasive Extraintestinal Pathogenic Escherichia coli Disease
  3. 0.9% sodium chloride, GB-0895 Phase 3 · Generate Biomedicines · severe uncontrolled asthma
  4. 0.9% sodium chloride, Lepodisiran Phase 3 · Eli Lilly and · Atherosclerotic Cardiovascular Disease Elevated lp(a)
  5. 213823 Phase 3 · GSK Glaxo Smith · Lung Cancer, Non-Small Cell
  6. 221530 Phase 3 · GSK Glaxo Smith · Neoplasms, Head and Neck
  7. 222725 Phase 3 · GSK Glaxo Smith · Chronic Obstructive Pulmonary Disease
  8. 224295 Phase 3 · GSK Glaxo Smith · Chronic Obstructive Pulmonary Disease

Related patents

Browse patents BAXTER HEALTHCARE PTY LTD patent hub

  1. US 12338438

    Conjugated oligonucleotide compounds, methods of making and uses thereof

    Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12310943

    Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders

    Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12297182

    Compositions comprising an urolithin compound

    Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12226455

    Medical composition for treating cardiac wasting and cachexia

    Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12220424

    Compositions comprising nicotinamide riboside and a urolithin

    Expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12146004

    Polymyxin compounds and uses thereof

    Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12109190

    Urolithins as immune response enhancers

    Expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12036205

    Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders

    Expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12030863

    Prodrugs of urolithins and uses thereof

    Expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11975066

    Ungulate-derived polyclonal immunoglobulin specific for coronavirus protein and uses thereof

    Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11969408

    Method for improving mitophagy in subjects

    Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11925616

    Compositions comprising urolithin compounds

    Expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11903922

    Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders

    Expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11878964

    Compositions comprising an urolithin compound

    Expires Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11459357

    Polymyxin compounds

    Expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11426380

    Urolithins as immune response enhancers

    Expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11337957

    Compositions comprising urolithin compounds

    Expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11234960

    Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders

    Expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11225506

    Cell penetrating peptides and methods of making and using thereof

    Expires Mon Jan 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11180468

    Prodrugs of urolithins and uses thereof

    Expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is sodium chloride?

sodium chloride (BAXTER HEALTHCARE PTY LTD) is an FDA-listed pharmaceutical active ingredient. Associated with BAXTER HEALTHCARE PTY LTD. Route of administration: irrigation. Current US regulatory status: approved.

What is the brand name for sodium chloride?

BAXTER HEALTHCARE PTY LTD is a marketed brand name for sodium chloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of sodium chloride?

sodium chloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.